Inventor · disambiguated record
Xinde Chen
Also filed as: CHEN XINDE
5 granted patents·3 pending applications·5 citations·filing 2015–2023
66Inventor score
Files withMEDSHINE DISCOVERY INC3SHANGHAI INST MATERIA MEDICA CAS2TENCENT TECH SHENZHEN CO LTD2SHENZHEN WANHONG APPLE ELECTRONICSCO LTD1
Top patents by PatentIndex Score
8 records- 0178US11117899B2[1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitorMEDSHINE DISCOVERY INC·Filed 2018·Granted Sep 14, 2021·3 cites·23 claims
- 0275US10280146B2Pyrimidone compounds used as Lp-PLA2 inhibitors and pharmaceutical compositions thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2015·Granted May 7, 2019·2 cites·6 claims
- 0370US2023098398A1Molecular structure reconstruction method and apparatus, device, storage medium, and program productTENCENT TECH SHENZHEN CO LTD·Filed 2022·Application pending·0 cites
- 0460US10787422B2Pyrimidone compounds used as Lp-PLA2 inhibitors and pharmaceutical compositions thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2019·Granted Sep 29, 2020·0 cites·8 claims
- 0557US2023212174A1Pyrrolo[2,1-f][1,2,4]triazine derivative and use thereofTENCENT TECH SHENZHEN CO LTD·Filed 2023·Application pending·0 cites
- 0653US11649239B2Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1)MEDSHINE DISCOVERY INC·Filed 2019·Granted May 16, 2023·0 cites·12 claims
- 0742US12030897B2Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereofMEDSHINE DISCOVERY INC·Filed 2019·Granted Jul 9, 2024·0 cites·14 claims
- 0840US2024388837A1LoudspeakerSHENZHEN WANHONG APPLE ELECTRONICSCO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xinde Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →